Oral ganciclovir in the prevention of cytomegalovirus infection in postkidney transplant "CMV at risk" recipients: a controlled, comparative study of two regimens (750 mg Bid and 500 mg Bid)
- PMID: 9636560
- DOI: 10.1016/s0041-1345(98)00283-8
Oral ganciclovir in the prevention of cytomegalovirus infection in postkidney transplant "CMV at risk" recipients: a controlled, comparative study of two regimens (750 mg Bid and 500 mg Bid)
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical